These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2106534)

  • 21. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study.
    Okuma T; Yamashita I; Takahashi R; Itoh H; Otsuki S; Watanabe S; Sarai K; Hazama H; Inanaga K
    Pharmacopsychiatry; 1990 May; 23(3):143-50. PubMed ID: 1973844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haloperidol: therapeutic window in schizophrenia.
    Palao DJ; Arauxo A; Brunet M; Bernardo M; Haro JM; Ferrer J; Gonzalez-Monclus E
    J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma drug level and clinical response.
    Cooper TB; Volavka J; Czobor P
    J Clin Psychopharmacol; 1992 Apr; 12(2):134-6. PubMed ID: 1573036
    [No Abstract]   [Full Text] [Related]  

  • 24. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
    Möller HJ; Kissling W; Riehl T; Bäuml J; Binz U; Wendt G
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):127-36. PubMed ID: 2664882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose treatment with haloperidol: the effect of dose reduction.
    Volavka J; Cooper TB; Czobor P; Lindenmayer JP; Citrome LL; Mohr P; Bark N
    J Clin Psychopharmacol; 2000 Apr; 20(2):252-6. PubMed ID: 10770466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum prolactin as a correlate of clinical response to haloperidol.
    Van Putten T; Marder SR; Mintz J
    J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium for schizophrenia revisited: a systematic review and meta-analysis of randomized controlled trials.
    Leucht S; Kissling W; McGrath J
    J Clin Psychiatry; 2004 Feb; 65(2):177-86. PubMed ID: 15003070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium carbonate in chronic schizophrenia--a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients.
    Collins PJ; Larkin EP; Shubsachs AP
    Acta Psychiatr Scand; 1991 Aug; 84(2):150-4. PubMed ID: 1683094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-phase, double-blind randomized study of three haloperidol plasma levels for acute psychosis with reassignment of initial non-responders.
    Janicak PG; Javaid JI; Sharma RP; Leach A; Dowd S; Davis JM
    Acta Psychiatr Scand; 1997 Apr; 95(4):343-50. PubMed ID: 9150830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients.
    Ko GN; Korpi ER; Kirch DG
    J Clin Psychopharmacol; 1989 Jun; 9(3):186-90. PubMed ID: 2661607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder.
    Campbell M; Small AM; Green WH; Jennings SJ; Perry R; Bennett WG; Anderson L
    Arch Gen Psychiatry; 1984 Jul; 41(7):650-6. PubMed ID: 6428371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia.
    Lin CH; Kuo CC; Chou LS; Chen YH; Chen CC; Huang KH; Lane HY
    J Clin Psychopharmacol; 2010 Oct; 30(5):518-25. PubMed ID: 20814315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA; Miller BG
    Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic protocol for predicting plasma haloperidol concentrations.
    Miller DD; Perry PJ; Kelly MW; Coryell WH; Arndt SV
    J Clin Psychopharmacol; 1990 Jun; 10(3):207-12. PubMed ID: 2376619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania.
    Kramlinger KG; Post RM
    Acta Psychiatr Scand; 1989 Apr; 79(4):378-85. PubMed ID: 2500006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.
    Jibiki I; Kubota T; Fujimoto K; Sakamoto H; Hasegawa M; Furuta H; Yamaguchi N
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of carbamazepine in acute psychosis: a controlled study.
    Lenzi A; Lazzerini F; Grossi E; Massimetti G; Placidi GF
    J Int Med Res; 1986; 14(2):78-84. PubMed ID: 3084316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.